A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
about
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro.A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression.In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.Trends in Malignant Glioma Monoclonal Antibody Therapy.
P2860
A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel recombinant immunotoxi ...... murine models of glioblastoma
@en
type
label
A novel recombinant immunotoxi ...... murine models of glioblastoma
@en
prefLabel
A novel recombinant immunotoxi ...... murine models of glioblastoma
@en
P2860
P356
P1433
P1476
A novel recombinant immunotoxi ...... murine models of glioblastoma
@en
P2093
Vidyalakshmi Chandramohan
P2860
P304
P356
10.4161/ONCI.26852
P577
2013-10-22T00:00:00Z